secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tango Therapeutics, Inc. (TNGX)
CIK:        0001819133
Form:       8-K
Filed at:   2023-06-07T23:59:59+00:00
Accession:  0001193125-23-162609
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tango Therapeutics stockholders elect two Class II directors and ratify PwC as auditor
--------------------------------------------------------------------------------

- Malte Peters, M.D. elected with 75,943,817 votes for, 3,532,483 withheld (5,145,731 broker non-votes).
- Mace Rothenberg, M.D. elected with 76,746,614 votes for, 2,729,682 withheld (5,145,731 broker non-votes).
- Ratification of PricewaterhouseCoopers as auditor: 84,619,141 for, 2,888 against, 2 abstain.
- Quorum of 95.93% (84,622,031 of 88,209,964 shares) present at virtual annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819133/000119312523162609/0001193125-23-162609-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819133/000119312523162609/d512389d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-162609

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer